This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Earnings Watch: Stocks Under $5

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

7. Oxygen Biotherapeutics (OXBT)

Company Profile: Oxygen Biotherapeutics develops intravenous and topical medical products that deliver oxygen to tissues in the body. The company is currently focused on traumatic brain injury, wound healing, dermatologic indications and decompression sickness.

Earnings Reporting Date: July 14 (confirmed)

Current Share Price: $2.44

2011 Share Price Performance: 27%

Analyst Ratings: There are currently no analysts following Oxygen Biotherapeutics.

What To Watch For: Oxygen Biotherapeutics hasn't reported positive net income since the quarter ended April 30, 2010, although that can be typical for a development stage biomedical company. Shares of Oxygen have managed to stay positive even after a sharp drop last month following the company's announcement of a $4.6 million private placement. For more upside, investors should be on watch for management comments on the company's Dermacyte skin care products and additional distribution agreements.

6. Ossen Innovation (OSN)

Company Profile: Ossen Innovation is a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials.

Earnings Reporting Date: July 15 (unconfirmed)

Current Share Price: $3.19

2011 Share Price Performance: -32%

Analyst Ratings: Ossen Innovation is followed only by Global Hunter Securities, which rates the stock as a "buy."

What To Watch For: Ossen Chairman Liang Tang said he expects the company to grow revenue in 2011 to $138.5 million to $144.6 million, compared with $117.5 million in 2010. Investors should keep an eye on the company's margins as Tang has said he expects gross margins for coated products to increase to 25% to 30% from 23% due to a shortage of coated pre-stressed steel materials.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
SVBL $0.06 1.79%
JOEZ $5.95 13.98%
IBCA $10.78 1.99%
MSN $0.93 -1.07%
PPHM $0.86 -2.27%


Chart of I:DJI
DOW 15,914.74 -99.64 -0.62%
S&P 500 1,851.86 -0.35 -0.02%
NASDAQ 4,283.5920 +14.8290 0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs